David Solit

Director, Developmental Therapeutics; Associate Professor of Medicine; Cell and Developmental Biology, Memorial Sloan Kettering Cancer Center

David Solit

Director, Developmental Therapeutics; Associate Professor of Medicine; Cell and Developmental Biology, Memorial Sloan Kettering Cancer Center
Share
Share

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

David Solit discloses the following relationships and financial interests:

  • American Association for Cancer Research
    Provision of Services
  • Apple Tree Life Sciences, Inc.
    Provision of Services
  • BridgeBio Inc.
    Provision of Services
  • NovellusDx Ltd.
    Ownership / Equity Interests; Provision of Services
  • Pfizer, Inc.
    Provision of Services
  • Scorpion Therapeutics, Inc.
    Ownership / Equity Interests; Provision of Services
  • Vividion Therapeutics
    Ownership / Equity Interests; Provision of Services

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures